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ABSTRACT 
 
While the association between low birth weight (LBW; <2500 g) and development of adult 
chronic renal disease (CKD) is inconsistently reported, less information is available regarding 
association of high birth weight (HBW; ≥4000 g) with CKD. We undertook a systematic 
review and meta-analysis on studies published before 30 September 2015 and report 
associations between birth weight and renal function. Blood [Glomerular filtration rate 
(GFR)] and urine [Microalbuminuria/Albumin excreation rate (AER)/urinary albumin 
creatinine ratio (ACR)] parameters were used to define CKD. Three different effect size 
estimates were used (odds ratio, regression coefficient, and mean difference). The odds of 
developing CKD in the life course among those born LBW was 1.77 (95% CI:1.42, 2.20) 
times  and 1.68 (1.27, 2.33) times, assessed by blood and urine parameters respectively. 
Higher risk was also observed among Asian and Australian populations (blood: OR 2.68; 
urine: OR 2.28), individuals aged ≤30 years (blood: OR2.30; urine: OR 1.26), and ≥50 years 
(blood: OR 3.66; urine: OR 3.10), people with diabetes (blood: OR2.51), and aborigines 
(urine: OR 2.32). There was no significant association between HBW and CKD.  For every 
one kg increase in BW, the estimated GFR increased by 2.09 ml/min/1.73 m
2 
(1.33-2.85) and 
it was negatively associated with LogACR (ß-0.07, 95% CI: -0.14, 0.00). LBW inborn had 
lower mean GFR -4.62 (-7.10, -2.14) compared to normal BW. Findings of this study suggest 
that LBW increased the risk of developing CKD and HBW did not show any significant 
impact.  
 
INDEX WORDS: Birth weight, renal function, systematic review, meta-analysis  
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INTRODUCTION 
 
Over the last decades, the burden of chronic disease has increased at an alarming rate 
1-4
. 
Evidence from the recent past shows increasing prevalence of kidney disease, which has 
adversely affected the health system as well as imposing an enormous social and community 
burden globally irrespective of country economic status 
5, 6
. Several epidemiological and 
experimental studies suggested that most of the chronic diseases including chronic kidney 
disease (CKD) are linked with in utero life as first stated by Barker’s hypothesis of “early 
origins of late disease” 7. This is supported by Bernner’s hypothesis, which proposes that an 
inborn nephron deficit due to intra-uterine growth retardation (IUGR) or low birth weight 
(LBW) predicts long term risks of hypertension, renal impairment or decreased glomerular 
function, age adjusted glomerulosclerosis and later  CKD or end stage renal disease (ESRD) 
8
. Moreover, further adverse events during extra-uterine life or life style during pregnancy 
may exacerbate the ramifications on renal function resulting in CKD 
9
. 
 
The association between LBW and CKD is not consistent due to heterogeneity in age of 
diagnosis, geographical diversity and ethnic variation. Moreover, use of different biomarkers 
and formulae to determine CKD might also contribute to heterogeneity 
10
. Usually, 
glomerular filtration rate (GFR) is one of the easiest methods; but the use of different 
formulas and different biomarkers for example serum creatinine, serum cystatin are still of 
great concerns 
11
.  Further,  microalbuminuria is also a well-recognized biomarker for early 
prediction and diagnosis of CKD 
12
.   
 
White  SL et al. in 2009 made an attempt to harmonize such inconsistencies by including 
findings of all studies published before January 2008, and estimated the risks of albuminuria, 
  
This article is protected by copyright. All rights reserved. 
ESRD and low estimated GFR (eGFR) as odds ratios (ORs) of 1.81, 1.58, and 1.79 among 
respectively newborns with LBW 
10
. However, the study used traditional methods without 
controlling for heterogeneity across studies and reported the outcomes only in OR as a 
measure of effect size.  Another review by Rong XU et al. in 2010 examined the role of LBW 
in pathogenesis of CKD and included studies which reported mean difference of GFR 
between LBW and normal weight as control 
13
.  This study also had similar methodological 
limitations.  
 
Recent studies consistently found that HBW increased obesity or metabolic risk irrespective 
of age and sex, which is explained by the over-nutrition hypothesis 
14, 15
.  This might suggest 
that HBW is likely to increase the risk of CKD through the obesity pathways. However, no 
such associations have ever been described for newborns with high birth weight (HBW) and 
the available analyses do not consider the linear associations between LBW and renal 
function using different biomarkers. Thus, the present appraisal aimed to determine the 
pooled estimation of association of birth weight (LBW and HBW) with CKD by using 
different biomarkers (blood and urine), including a variety of estimates of effect sizes and 
models. Moreover, we also aimed to determine the at risk population by including other 
factors such as geographical diversity, age differentials, effect of underling predictors such as 
diabetes and hypertension and ethnic difference.  
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METHODS   
 
Search strategy 
 
A systematic review of all published study findings irrespective of age, sex and ethnicity was 
undertaken in accordance with preferred reporting items for Systematic Review and meta-
analysis guideline in PubMed (www.ncbi.nlm.nih.gov), Embase and Scopus till October 28, 
2015. We searched for articles examining the association of birth weight and renal failure 
(chronic kidney disease) across different age groups. To search the articles no limits were 
inserted and references from the relevant literature were hand searched and used to identify 
additional relevant studies. The key words used for searching were, “birth weight,  low birth 
weight/LBW, infant-low birth weight,  high birth weight, foetal/fetal growth retardation, 
intrauterine growth retardation or IUGR, foetal/fetal development, small for Gestational 
age/SGA”  with  “kidney, renal, kidney function, renal function, kidney failure, renal failure, 
kidney disease, renal disease, kidney function impairment,  renal function impairment,  
chronic kidney disease/CKD, glomerular filtration rate/GFR, glomerular filtration, 
proteinuria”. We retrieved 15,565 articles and based on the information related to topic, 
abstract and full-text articles, a total of 15,514 studies were rejected, as they clearly did not 
meet the inclusion criteria (see below). A total of 51 studies were finally included for this 
study. The search strategy is described in detail in the online appendix.  
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Inclusion and exclusion criteria 
 
Studies were included if they: 1) were published in the English language; 2) used the 
following study designs - cohort, case-control, cross-sectional, randomized control trial; 3) 
included people of any age >1 year, sex and  ethnicity; 4)  assessed the association of LBW 
with CKD by odds ratio, regression co-efficient and  mean difference. The exclusion criteria 
were: 1) case reports, qualitative reports, comments, letters and reviews 2) animal or 
experimental models, 3) renal impairment or assessment of renal function as neonate and less 
than one year, and 4) other renal pathology such as minimal change nephropathy, 
immunoglobulin A nephropathy, and nephritic syndrome.  
 
Data extraction and quality appraisal  
 
A standard data extraction form summarizing the study design and other relevant raw data 
was completed for each article by an independent reviewer following PICOS guideline 
16
 
(Table S1). Studies reporting their outcomes in odds ratios were synthesized. In some cases 
the effect sizes were transformed, that is converted into odds ratio (OR) when the necessary 
data for calculation were available. Data synthesis was also undertaken for standard error 
(SE) and standard deviation (SD) among studies with linear association or mean difference. A 
quality-scoring instrument (Table S2) was developed based on standard bias criteria for 
observational studies to adjust for study deficiencies. This instrument meets the criteria of 
New Castle Ottawa score (selection, completeness and outcome) for both cohort and 
case-control studies 
17, 18
.  Following the standard procedure quality scoring was done by 
two reviewers. Any disagreement in the scoring was resolved by consensus and each item 
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that was not deficient was given a point. These were then summed to form a univariate 
quality score (Table S3). 
 
Primary analysis 
 
Three different outcomes have been measured: 1) estimation of risk by Odds ratio; 2) 
estimation of linear association by regression coefficient; and 3) estimation of risk by mean 
difference. Pooled estimations were equated for each outcome based on assessment of renal 
function by two biomarkers separately: blood (eGFR) and urine [Microalbuminuria/Albumin 
excretion rate (AER)/urinary albumin creatinine ratio (ACR)]. To adjust for bias, the pooled 
estimates were obtained using three different meta-analytic models, given that the random 
effects (RE) model 
19
 is known to underestimate the statistical error which could lead to 
overconfident results 
20-22
. Two other statistical approaches were used - the bias adjusted 
quality effects (QE) model 
17
 and its bias unadjusted variant called the inverse variance 
heterogeneity (IVhet) model 
23
. The quality effects (QE) model adds a synthetic bias variance 
based on relative quality ranking. However, both the QE and the IVhet models use quasi-
likelihood based variance structure without distributional assumptions and thus have 
coverage probabilities for the confidence interval (CI) well within the 95% nominal level.  
Both  have been documented to have a better performance when compared to the RE method 
23. Heterogeneity was determined to be present when the value of τ2 was greater than zero 
and/or the Q-statistic was significant at a P < 0.10 
24
. All analyses were done using MetaXL 
version 2.0 
25
. 
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Sensitivity analysis and publication bias 
 
Sensitivity analyses were performed with the aim to evaluate the robustness of our meta-
analysis by changing selection criteria of the studies based on their regional difference, age of 
assessment (<30 years, 31-50 years, and 51 and above years), presence of potential predictors 
such as diabetes, and ethnicity variation. Finally, analysis of the effect of potential 
unpublished studies was undertaken to evaluate the possibility of publication bias within this 
meta-analysis. Publication bias was assessed via funnel plots as well as Peter’s regression 
(when the effect size was calculated in OR) and Egger’s regression. For Peter’s and Egger’s 
regression, asymmetry of the studies was considered if the intercept of regression deviated 
from zero with P <0.10 
26
.  
 
RESULTS 
 
Study characteristics 
 
Overall characteristics 
 
A total of 51 
27-77
 relevant papers finally met the inclusion and exclusion. Of them, 36 
followed a cohort design 
27-30, 32, 34, 36-44, 46-53, 56, 57, 59, 62, 63, 66, 67, 71-77
, nine a case-control design 
31, 35, 45, 54, 58, 60, 61, 64, 69, 70
 and five were of cross-sectional design 
29, 33, 55, 61, 65
 while one was a 
randomised control trial 
68
. Most of them collected birth weight retrospectively by chart-
review with only 4 studies collecting birth weight prospectively 
37, 39, 50, 62
 from birth records. 
One recorded self-reported 
30
 birth weight and three did not mention their methodology 
43, 54, 
60
.  Eight studies included patients attending hospitals or clinics where they were enrolled 
37, 
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45, 56, 61, 66, 67, 71, 74
, while the remainder were community based. One community based study 
was conducted among kidney donors 
52
. A total of 2269188 individuals were assessed, 
including a single study from Norway 
47
 which comprised a population of more than 2 
million. A total of three studies were conducted among aboriginal populations: two from 
Australia 
29, 40
 and one from Canada 
49
. Considering the age of assessment of renal function, 
22 studies assessed renal function at less than 30 years 
28, 32, 33, 36, 40, 42, 43, 46, 47, 51, 54, 55, 58-62, 67, 
70, 73, 74, 77
.  Of these 11 were at paediatric and adolescent age group 
33, 40, 43, 51, 55, 60-62, 73, 74, 77
. 
On the other hand, there were five studies that had assessed renal function at aged 50 years 
and above 
34, 45, 48, 50, 52
 and the rest were at middle age (30-50 years). Four studies did not 
mention age clearly 
35, 56, 72, 76
. Two studies included twins 
57, 59
. In total 438 monozygotic and 
287 dizygotic twins were studied. Most of the studies either used blood or urine parameters to 
assess renal function; while only four studies analysed both specimens 
36, 44, 50, 55
. Blood was 
used for estimation of GFR to define CKD or ESRD 
31, 35, 38, 41, 42, 44, 45, 47, 52, 76
 from serum 
creatinine; while microalbuminuria  was used to determine CKD from urine to estimate 
urinary albumin creatinine ration (ACR) 
27, 29, 32, 33, 36, 37, 39, 50, 52, 53, 55-57, 62, 68, 72
 and albumin 
excretion rate (AER) 
28, 34, 39, 40, 43, 65-67, 69, 74
 to ascertain the association with birth weight. 
Moreover, five studies reported very low birth weight 
36, 55, 58, 60, 62
. 
 
Studies estimated the risk of CKD or ESRD, and mean difference, most of them considered 
newborns with birth weight <2500 g and compared with those of normal birth weight (2500-
3999 g). However, one study estimated ponderal index (lower 3
rd
 percentile) 
34
,  two studies 
estimated birth weight percentile 
39, 42
 and one study considered intra uterine growth 
retardation 
62
. Ten studies reported the association between HBW and CKD 
27, 31, 35, 38, 39, 43, 44, 
47, 49, 54
.  
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Study quality 
 
Of 36 studies included in meta-analysis, 21 estimated the effect size in OR 
27-35, 37-41, 43-45, 47, 49, 
52, 54
, six studies estimated regression coefficients 
36, 46, 48, 50, 51, 53
, eight studies measured as 
mean difference 
55-62
, four of the studies estimated both OR and mean difference 
29, 32, 39, 52
, 
one study reported both OR and regression coefficient 
42
, one measured both mean difference 
and regression coefficient 
36
. Four studies used cross-sectional samples 
29, 33, 55, 61
 and six 
were case-control 
31, 35, 45, 54, 58, 60
 study designs, suggesting a possible source of design-
specific bias. Most of the studies had well documented study designs and inclusion criteria 
except for two studies that reported this poorly 
29, 40
. Six studies examined confounding 
factors extensively (≥7 confounders) 37, 43, 44, 47, 50, 52, while 13 studies did not include any 
confounding factors 
28, 29, 35, 41, 46, 49, 55-58, 60, 62, 74
 and the remainder  of the studies included one 
to seven confounders to measure the association. Only eight studies were conducted in 
populations with diabetes and/or hypertension and/or family history of CKD, diabetes, or 
hypertension 
27, 28, 34, 38, 39, 43, 44, 50
. Only seven studies estimated risk or association adjusted 
for single maternal factors (gestational age 
39, 51
, maternal diabetes 
42, 43, 53
, maternal BMI 
53, 
54
).  One study included four factors for adjustment (maternal age, diabetes, preeclampsia and 
renal function) 
42
 and another study considered three factors (age, marital status and 
preeclampsia) to measure the association between birth weight and renal function  
47
. Two 
studies considered the behavioural factor of smoking 
37, 48
. All but four studies 
30, 43, 54, 60
 
recorded documented (birth record) birth weight. Studies estimating risk for CKD used 
standard cut-offs [either eGFR (<60 ml/min/1.73 m2) or ACR (≥30 g/mol)]; however, some 
studies considered CKD by ACR ≥2.5 g/mol 37, 39, 49 and four considered AER >15 g/mol 28, 
34, 39, 43
], while four studies assessed ESRD 
31, 35, 38, 47
. The quality was assessed for all the 
studies individually, and the corresponding quality scores are shown in Supporting 
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Information Table S3. The quality assessment was summed into a univariate score with a 
maximum of 15 points and studies ranged between 4 and 15. 
 
Meta-analysis  
 
Newborns with LBW were at 1.77 (95% CI: 1.42, 2.20) and 1.68 (1.27, 2.33) times higher 
risk of CKD in later life assessed by blood and urine respectively (Figure 2). On the other 
hand, in newborns with HBW, overall risk of CKD at adulthood was 1.09 (0.91-1.32) times 
higher than normal birth weight individuals and for blood it was 1.04 and for urine 1.11 
(Figure 3). 
 
Two pooled linear estimations were undertaken due to heterogeneity across studies in 
measuring renal function. Firstly, for eGFR, every 1 kg increase in birth weight was 
positively associated with a change in eGFR of 2.09 ml/min/1.73 m
2 
(95% CI: 1.33, 2.85). On 
the other hand,  log transformed ACR was significantly and negatively associated [-0.07 (-
0.14, 0.00)] with birth weight (Figure 4).    
   
Two separate pooled estimates were calculated for GFR and ACR to determine mean 
differences. The pooled estimate for GFR revealed that individuals with LBW had lower 
mean GFR 4.62 ml/min/1.73 m
2 
(95% CI: -7.10, -2.14) compared to their counterpart with 
normal birth weight (Figure 5). However, lower mean ACR 1.09 (-2.32, 0.14) was found 
among individuals with LBW, which was not statistically significant. 
 
In sensitivity analyses, Asians and Australians were at greater risk (OR: blood - 2.68; urine - 
2.28) compared to Europeans (OR: blood - 1.85; urine - 1.56) and individuals from USA and 
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Canada (1.59; 1.64) (Table 4). Individuals aged above 50 years were at higher risk (3.66; 
3.10) compared to middle aged participants (31-49 years). However, higher risks were also 
observed among the young adult and paediatric age group (2.30; 1.26) compared to middle 
age (30-49 years) participants. Individuals with diabetes were at higher chance of developing 
CKD compared to non-diabetic people as assessed by blood (2.51 vs. 1.85) (Table 4).  LBW 
aborigines were at higher risk of CKD in adulthood compare to non-aborigines (2.32 vs. 
1.50) assessed by urine only (Table 4).  
 
Publication bias 
 
The funnel plots were symmetrical (for all the studies which measured the risk in OR, linear 
association and mean difference) suggesting no publication bias. Further, Peter’s regressions 
for OR were examined and publication bias was not found for LBW with CKD for blood 
(regression coefficient: 0.001; P =0.03) or for urine (regression coefficient: 0.002; P=0.04). 
For HBW there was some evidence of bias (regression coefficient: <0.001; P=0.07). The 
intercepts for the association between BW and GFR (-0.020; P=0.96) and ACR (0.025; 
P=0.36) on Egger’s regression also included zero, suggesting absence of publication bias in 
the studies included in this meta-analysis. Therefore, publication bias does not appear to be 
an important consideration for this study. On the other hand, regression coefficient for mean 
difference for eGFR (2.21, p=0.004) and ACR (0.70; p=0.020) indicated presence of 
publication bias.    
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DISCUSSION 
 
Predisposition towards pathophysiological changes in smaller or immature kidneys includes 
lower numbers of nephrons at birth or early loss of nephrons. Later (mal) adaptive 
mechanisms include increased capillary pressure and glomerular hypertrophy resulting in 
intraglomerular hypertension which accelerates nephron attrition and progression towards 
CKD among newborns with LBW 
8, 78, 79
.  In the present study, inborn with LBW were at 
1.77 and 1.68 times higher risk for CKD compared to normal birth weight newborns, which is 
consistent with the  previous study published in 2008 
10
 that reported increased odds of 1.73 
with both combined blood and urine measures. We found both blood and urine analyses have 
similar sensitivity in detecting renal impairment, whilst urine analysis has potential practical 
advantages, as it is a non-invasive and cost effective method.  
 
Newborns with HBW are also at 1.09 times higher risk of CKD at later life, though the 
association is not statistically significant. We found ten studies which ascertained the 
association between HBW and CKD 
27, 31, 35, 38, 39, 43, 44, 47, 49, 54
. Only one study) among Pima 
Indians with diabetes) showed high odds ratio for CKD, which did not appear representative 
of the general population 
27
.  This might be due to intrauterine diabetes exposure as reported 
by Nelson 
27
, as HBW may be associated with later development of autoimmune disease 
80-82
, 
metabolic syndrome 
14
 and ESRD due to diabetic nephropathy 
31
. Alternatively, it might be 
linked with sustained excess weight gain leading to overweight and obesity. A recent review 
among individuals with renal disease reported an association between childhood obesity and 
increased risk of onset renal disease 
83
. Several other longitudinal studies also demonstrate an 
association between obesity and incidence of CKD at adulthood especially among adults 
50, 
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84
. Moreover, association with overweight first detected at a younger age with increased risk 
of CKD had also been documented 
85
.   
 
We also estimated other pooled associations between birth weight and renal function such as 
linear association (beta coefficient), and mean difference.  In all cases, the magnitude of 
association between birth weight and CKD was also similar to that of risk estimation between 
LBW and CKD. For example in the linear model, every 1 kg increase in birth weight was 
positively associated with change in eGFR of 2.09 ml/min/1.73 m
2
. Considering mean 
difference, newborns with LBW had lower GFR by 4.62 ml/min/1.73 m
2 
compared to their 
counterpart with normal birth weight which is higher than the previous estimation done by 
Rong XU in 2010 
86
.  
 
LBW newborns from Asia and Australia appear to be more at risk of CKD compared to 
European, and American and Canadians.  Recent studies show that the prevalence of CKD 
has been increasing in most of the Asian countries. Taiwan, Japan, South Korea, Malaysia 
and India are within the top 20 countries globally with highest annual incidence of CKD 
6
. A 
study from Singapore also reported higher odds (2.09) of CKD among 6
th
 grade school 
children with LBW 
33
. A study from Japan has also demonstrated a positive correlation 
between the annual incidence of LBW and of ESRD 
76
. Such correlations could not be 
estimated for other Asian countries, perhaps due to poor national birth registration systems as 
well as unavailability of life course health status registers 
87
. However, prevalence of LBW is 
15% based on available records of birth weight in developing and least developed countries, 
with higher prevalence (25%) in South Asians according to UNICEF 
87
. On the other hand, 
among the Australian population the odds of CKD among LBW individual in adulthood was 
also higher. According to the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) the 
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prevalence of CKD among the general population over the last decade increased from 4% to 
5% (20% percent increase) with an incidence of impaired eGFR of 0.4% per year 
88
. 
 
Food contamination is currently a great public health threat, especially in developing 
countries. As the kidney is the main organ responsible for extracting and eliminating all the 
consumed health hazardous additive chemicals 
89
, resultant hyper activation of the glomerular 
membrane and toxic sedimentation might alter the renal homeostasis. Moreover, unplanned 
urbanization reduces open space, which compounds the risks of sedentary lifestyle and lower 
physical activity.  These factors, in addition to environmental pollution may also increase the 
risk of diabetes and hypertension. Diabetes accelerates progression of vascular disease and 
carries a substantially increased risk of renal failure, while hypertension causes 
nephrosclerosis. Thus, both diabetes and hypertension are major predictors for renal 
impairment and the development of CKD. In the present study, odds of CKD were higher 
among diabetics compared to non-diabetics born with LBW.  Among Australians, diabetes 
itself is responsible for 35% of all newly diagnosed ESRD, whereas hypertension and 
atherosclerosis account for 15% 
88
.  It has also been observed that aboriginal LBW newborns 
in Australia 
29, 40
 and Canada 
49
 are at higher risk of CKD in later life, which once again 
strengthens the evidence for vulnerability to chronic disease in these  populations as reported 
elsewhere 
90, 91
.  
 
Age of onset of CKD is another area of controversy due to inconsistency in the assessment of 
renal function. Though CKD is thought to a disease of older age due to degenerative changes 
and organ malfunction, young children born with LBW are also at greater risk 
33, 40, 51, 55, 60, 61, 
73, 74, 77
. It is difficult to precisely explain the complex relationship between the pathway(s) 
potentially connecting LBW and CKD in early life and young adulthood, and to define which 
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specific factors contribute to disease progression mostly due to different causes of CKD in 
children and adult.  Evidences showed higher albuminuria may depends on ethnicity 
29, 
32, 64
, high blood pressure 
92
 due to raised natriuresis (also hormone or hormone like 
substance involvement 
93
) or alteration of Na
+
/K
+
-ATPase activity 
32
. Change in body 
weight with environmental exposure and relationship between LBW with early onset of 
other metabolic disorder for example diabetes 
94
 in addition lower number of nephrons 
might be alternatively speculated the relation of LBW with CKD among pediatric and 
early adult age groups; however, further studies are needed in this area. However, 
interestingly no evidence of CKD was found among kidney donors with LBW 
52
.  This could 
be due to post donation well-maintained life-style and behaviour or selection pre donation for 
overall health and normal renal function. A significant relationship has also been reported 
between LBW and ESRD among females 
35
.  This could be biologically based - sex 
differences in kidney size and BW with CKD have reported elsewhere 
44
.  However, such a 
differential might also be caused by creatinine-based sex adjusted estimation of GFR 
formulae 
95
. Conversely, a significant association between LBW and CKD was reported only 
among males by Li S et.al. 
44
.   
 
Maternal pre-pregnancy and pregnancy events, and life-style and behavioral factors such as 
diabetes, eclampsia or pre-eclampsia; smoking and alcohol consumption are important 
predictors which are recorded in only 3 studies. All of these are not merely confounders but 
also may be intermediate factors in the causal pathway of compromised organogenesis in 
utero and incipient nephropathy in offspring at adulthood reported elsewhere 
28
. Only a few 
studies have estimated the risk of CKD by adjusting for the participants’ life-style and 
behavioral factors 
37, 42, 48
. Moreover, maternal nutrition during gestation (especially under 
nutrition) has been linked to impaired renal function in the twin offspring.  For example, as 
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reported by Painter RC 
37
, mid trimester Dutch pregnant mothers who were exposed to 
famine had higher rates of offspring microalbuminuria at age 50. Positive associations 
between intra-pair differences in size at birth and subsequent intra-pair differences in 
creatinine clearance in later life suggest that the relationship between birth weight and 
subsequent kidney function is robust to confounding by maternal and early life factors. 
However, no significant increase in the prevalence of microalbuminuria or albumin excretion 
rate was observed for individuals exposed to intrauterine maternal starvation during the 3-
year siege of Leningrad 
50
. Moreover, maternal obesity is also associated with malformations 
of offspring urogenital system 
96
 which again could be related with maternal diabetes though 
the findings are not consistent 
97
.   
 
STREGTHS AND LIMITATIONS  
 
Retrospective collection of birth weight from a record in most of the studies accentuated the 
chance of misclassification bias due to uncertainty in availability of valid records from all the 
study participants as well as lack of opportunity to compare with individuals without any 
record. Limited availability of information regarding maternal pre-pregnancy and pregnancy 
events are other concerns. Only 3 studies considered such potentially important information–
especially relating to diabetes and eclampsia 
42, 43, 47
. Such information was also lacking for 
study participants. Moreover, age of assessment, study designs other than longitudinal study, 
risk estimation by odds ratio, use of different biomarkers for defining CKD were other 
limitations. Despite all of these potential limitations, the use of biomarker based independent 
analysis, the use of three different effect size estimates to determine associations between 
LBW and CKD, the use of three different models for pooled estimations as well as several 
sensitivity analyses with extra effort for controlling bias were the strengths.     
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CONCLUSIONS 
 
Findings from the present study indicate a relationship between LBW and CKD. Newborns 
with LBW are at greater risk of developing CKD or impairment of renal function in 
adulthood. The causal relationship could be linked with organogenesis.  Lack of information 
regarding maternal, perinatal and antenatal lifestyle and behaviour and the offspring’s’ socio-
demographic indicators at adulthood, limits definitive conclusions.  However, the progression 
of renal impairment in LBW newborns is still of great concern, even after identifying 
potential confounders. Given the epidemic of diabetes and our finding that at least one-third 
of people with diabetes experienced CKD and LBW, this risk is of great importance. Further, 
prevalence in Asia is particularly high and diabetes is also associated with social 
disadvantage people as seen in aboriginal groups. LBW needs to be examined in conjunction 
with other risk factors and diseases such obesity, hypertension, and coronary heath disease in 
terms of its relative contribution to later renal disease. Moreover, the potential association 
between HBW and CKD, though not significant in this meta-analysis, needs to be explored in 
detail given the progression of the global epidemic of overweight and obesity.       
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Figure 1: Selection framing of literature for systematic review and meta-analysis 
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Figure 2: Meta-analysis of the risk of chronic renal disease among inborn with low birth 
weight assessed by blood and urine at adulthood 
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Figure 3: Meta-analysis of the risk of chronic renal failure among inborn with high birth with 
at adulthood 
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Figure 4: Meta-analysis of the linear association between birth weight and glomerular 
filtration rate, and log transformed albumin creatinine ration 
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Figure 5: Meta-analysis of the difference of glomerular filtration rate and albumin 
creatinine ration between LBW and NBW people in adulthood 
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Table 1: Summary tables of studies measure Chronic Renal Disease and use effect size as Odds ratio/Beta-coefficient  
  
  Study 
name 
Place Study 
design  
N Age 
(year; 
mean±SD
) and sex 
Patient’s 
character; 
birth weight 
(g) 
[mean±SD; 
range] 
Specimen; 
Biomarker 
Findings  Exposure 
(reference) 
OR/β 
(95% CI) 
Adjusted/Potentia
l predictors  
1 Nelson 
RG, et al. 
(1998) 
27
 
United 
States 
Chort 
study 
30
8 
34±6; 
both sex 
Pima and 
closely-
related 
Tohono 
O'odham 
Indians with 
Type 2 DM; 
[3382±575; 
1619-5386] 
Urine; 
Microalbum
inuria: 
ACR≥30 
mg/g 
Significant U-shaped 
association between 
BW & 
microalbuminuria 
prevalence 
BW<2,500 
g (vs. 
2,500-4,499 
g) 
2.3 (0.72, 
7.2) 
Age, sex, duration 
of DM, 
hemoglobin A1c, 
mean arterial BP 
HBW 
≥4500 g 
3.2 (0.75-
13.4) 
2 Rudberg 
S, et al. 
(1998) 
28
 
Sweden Nested 
case-
control 
study, 
populati
on-
based 
cohort 
21
4 
Cases, 
20.2±4.0; 
controls, 
18.7±5.1; 
both sex 
IDDM 
(controls 
matched for 
DM duration) 
[case:3573±5
83; 
control:3614±
465] 
Urine; 
Microalbum
inuria: 
AER≥15 
micg/min 
No significant 
association between 
LBW and 
microalbuminuria 
prevalence 
BW <2,500 
g (v ≥2,500 
gm) 
2.77 (0.77, 
9.94) 
Unadjusted 
3 Hoy WE, Australi Cross- 21 20-38 High-risk Urine; LBW associated with BW <2,500 2.82 (1.26, Age, sex, BMI, 
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et al. 
(1999) 
29
 
a sectional 7 (range); 
both sex 
Aboriginal 
community; 
[2712±460; 
(1470-4080)] 
Microalbum
inuria: 
ACR≥300 
mg/g 
high rates of 
macroalbuminuria in 
high-risk community 
g (v ≥2,500 
g) 
6.31) SBP 
4 Poulter 
NR, et al. 
(1999) 
30
 
United 
Kingdo
m 
Retrospe
ctive 
cohort 
study 
26
02 
45.5; 
female 
Volunteers 
for registry of 
adult twins 
eGFR<10th 
sex specific 
percentile 
(MDRD 
Study                                               
equation) 
No association between 
LBW and eGFR among 
twin female 
(unpublished analysis)  
BW <2,500 
g (v 2,500-
3,999 g) 
1.31 (0.20, 
2.55) 
Age, sex, SES 
5 Lackland 
DT, et al. 
(2000) 
31
 
USA Case-
control 
study 
26
90 
34 
(median); 
both sex 
Cases had 
recent 
dialysis; 
Controls 
matched for 
age, sex, 
ethnicity; 
[black:3210; 
white:3361] 
ESRD LBW significantly 
contribute to early 
onset of ESRD  
BW <2,500 
g (v 3,000-
3,499 g) 
1.40 (1.1, 
1.8) 
Unadjusted 
HBW does not 
significantly contribute 
to early onset of ESRD 
HBW 
≥4000 g 
1.1 (0.9, 
1.4) 
6 Vasarhel
yi B, et 
al. (2000) 
32
 
Hungar
y 
Cohort 
study 
12
6 
18-22 
(range); 
both sex 
Healthy 
adolescents 
Urine; 
Microalbum
inuria: 
ACR≥30 
mg/g 
No association between 
LBW and kidney 
function observed 
BW <2,500 
g (v 2,500-
3,999 g) 
0.71 (0.20, 
2.55) 
Sex 
7 Ramirez 
SP, et al. 
Singap Cross- 13 12; both Children at 6
th
 
grade level or 
Urine; 
Proteinuria:  
Trend toward for  LBW 
in children with 
BW <2,500 
g (v ≥2,500 
2.09 (0.44, Sex, ethnicity,  
prematurity, 
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(2001) 
33
 ore sectional  26 sex 12-years 
under pilot 
national 
screening 
program; 
[3173±607] 
≥1+ (≥30 
mg/dL of 
protein) by 
dipstick  
proteinuria g) 9.21) current weight, 
mean arterial BP 
8 Yudkin 
JS, et al. 
(2001) 
34
 
 
United 
Kingdo
m 
Cohort 
study 
81
8 
61.4±7.4; 
both sex 
Born in Ware, 
Hertfordshire, 
Preston, 
Lancashire; 
[3402±561] 
Urine; 
Microalbum
inuria: 
AER>20  
micg/min 
Significant trend 
toward higher 
prevalence of 
microalbuminuria with 
lower ponderal index 
Ponderal 
index in 
lower 
3
rd
percentil
e (v highest 
3rd) 
3.10 (0.90, 
11.30) 
Age, sex, BMI, 
SBP, region, 
fasting glucose 
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Table 1: Summary tables of studies measure estimated Chronic Renal Disease and use effect size as Odds ratio/Beta-coefficient (continuation) 
 
  Study 
name 
Place Study 
design  
N Age 
(year; 
mean±SD
) and sex 
Patient’s 
character 
Biomarker Findings  Exposure 
(reference) 
OR/β 
(95% CI) 
Adjusted/Potentia
l predictors 
9 Dyck R, 
et al. 
(2003) 
35
 
Canada Case-
control 
study 
87
8 
Both sex Indian & 
other 
Saskatchewan 
people; 
controls 
matched for 
age, sex, 
source 
population 
[case: 3776± 
538; 
control:3247±
558] 
ESRD 
 
LBW significantly 
associated with ESRD 
in white female 
BW <2,500 
g (v 2,501-
3,999 g) 
1.62 (0.88, 
2.96) 
Unadjusted 
HBW did not 
associated with ESRD  
HBW 
≥4000 g 
0.74 (0.44, 
1.20) 
1
0 
Keijzer-
Veen 
MG, et 
al. (2005) 
36
 
The 
Netherl
ands  
Cohort 
study 
42
2 
19.3±0.2; 
both sex 
Born with a 
gestational 
age <32 wk. 
GFR  Birth weight (SDs) was 
associated with  GFR 
and Log ACR in young 
adults born very 
preterm 
 2.95 (1.66, 
4.24)* 
Sex 
LogACR -0.05 (-
0.09, -
0.01)* 
1
1 
Painter 
RC, et al. 
(2005) 
37
 
The 
Netherl
ands 
Cohort 
study 
72
4 
48-53; 
both sex 
Singletons 
born during 
Dutch famine 
(1944-1945); 
[3352±471] 
Microalbum
inuria: 
ACR≥2.5 
g/mol 
Exposure to famine 
mid gestation 
significantly associated 
with higher rates of 
offspring 
microalbuminuria at 50 
years 
Exposure to 
famine mid 
gestation (v 
non 
exposed) 
3.22 (1.34, 
7.65) 
Age, sex, BMI, 
smoking, SES, 
SBP, IGT/NIDDM, 
cholesterol, ECG 
abnormalities 
1
2 
Fan ZJ, et 
al. (2006)  
38
 
United 
States 
Cohort 
study 
75
05 
18-50;  
ESRD, 
33.9±0.1; 
Medicaid 
beneficiaries 
(low income) 
with DM 
ESRD LBW significantly 
associated with ESRD, 
particularly in those 
with both DM & 
BW <2,500 
g (v 2,500-
3,999 g) 
1.56 (1.02, 
2.39) 
Age, sex, ethnicity, 
DM, hypertension 
  
This article is protected by copyright. All rights reserved. 
normal; 
37.6±0.6) 
; both sex 
&/or 
hypertension 
hypertension 
HBW was not 
associated with ESRD 
HBW 
≥4000 g 
1.29 (0.79, 
2.09) 
 
1
3 
Fagerudd 
J, et al. 
(2006) 
39
 
Finland Cohort 
study 
15
43 
33±10;  
both sex 
Type 1 DM 
with an age at 
onset <36 
years, with 
insulin 
therapy 
initiated 
within 1 year 
after 
diagnosis 
Diabetic 
nephropathy
: AER> 200  
micg/min, 
300 mg/24 
h; ACR 
>2.5/3.5 
mg/mmol 
(M/F), or 
ESRD 
No association between 
LBW and development 
of diabetic nephropathy 
BW <10th 
percentile 
(v 50th-
90th 
percentile) 
0.99 (0.61, 
1.62) 
Gestational age 
No association between 
HBW and development 
of diabetic nephropathy 
BW >90 
percentile 
(v 50th-
90th 
percentile) 
1.12 (0.60, 
2.08) 
1
4 
Haysom 
L, et al. 
(2007) 
40
 
Australi
a 
Cohort 
study 
13
82 
8.81±2.02 Aboriginal & 
non-
Aboriginal 
elementary 
school 
children 
Microalbum
inuria: 
ACR≥30 
mg/g 
No association between 
LBW and AEC 
(unpublished analysis) 
BW <2,500 
g (v 2,500-
3,999 g) 
0.95 (0.10, 
2.12) 
Age, sex, ethnicity, 
SES 
1
5 
Salmi A, 
et al. 
(2007) 
41
 
Australi
a 
Cohort 
study 
45
02 
≥25.0  Healthy 
adults 
eGFR<10th 
sex specific 
percentile 
(Taylor 
equation ) 
LBW significantly 
associated with eGFR 
& 10
th
percentile for sex 
BW <2,500 
g (v ≥2,500 
g) 
2.54 (1.54, 
4.18) 
Unadjusted 
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Table 1: Summary tables of studies measure estimated Chronic Renal Disease and use effect size as Odds ratio/Beta-coefficient (continuation) 
 
  Study 
name 
Place Study 
design  
N Age 
(year; 
mean±SD
) and sex 
Patient’s 
character 
Biomarker Findings  Exposure 
(reference) 
OR/β 
(95% CI) 
Adjusted/Potentia
l predictors 
16 Hallan 
S, et al. 
(2008) 
42
 
Norwa
y 
Cohort 
study 
74
57 
20-30; 
VSGA: 
24.2±2.8; 
SGA: 
24.7±2.9; 
AGA: 
24.7±2.9; 
both sex  
VSGA: 
2448±311; 
SGA:2851±2
53; AGA: 
3499±411 
eGFR<10th 
sex specific 
percentile 
(MDRD 
Study 
equation) 
IUGR significantly 
associated with low-
normal kidney function, 
effects less consistent in 
female 
BW <3rd v 
10th-90th 
percentile 
( 2,450 v 
2,870-4,190 
g) 
1.63 (0.76, 
3.5) 
Age, smoking, 
education, maternal 
factors (age, DM, 
kidney function, 
preeclampsia) 
3.45 (2.37, 
4.53)* 
17 Maahs 
DM, et 
al. 
(2008) 
43
 
United 
States  
Cohort 
study 
37
14 
12.3; both 
sex 
Youth 
younger than 
20 years with  
Urine; 
Microalbum
inuria: 
AER>20  
micg/min 
LBW was not 
significantly associated 
with elevated ACR 
LBW<2500 
g (v 
≥2,500-
4,000 g) 
1.15 (0.63, 
2.1) 
DM duration, age, 
sex, HbA1c%, 
gestational 
diabetic, ethnicity, 
DM type, BMI,  
SBP, DBP 
HBW was not 
significantly associated 
with elevated ACR 
HBW>4000 
g 
1.09 (0.69, 
1.73) 
18 Li S, et 
al. 
(2008) 
44
 
United 
States 
Retrospe
ctive 
cohort 
study 
12
36
4 
18-75; 
mean age: 
49.1-13.5 
both sex 
Volunteers 
with DM, 
HTN, or 
family history 
of CKD, DM, 
CKD: ACR 
30 mg/g or 
eGFR<60 
mL/min/1.7
3 m
2
 
LBW significantly 
associated with CKD 
only among male 
BW <2,500 
g (v 3,000-
3,999 g) 
1.25 (0.81, 
1.92) 
Age, race, 
education, 
insurance, region, 
DM, HTN, CVD, 
family history of 
HBW 1.10 (0.69, 
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or HTN; 
3195±781 
(MDRD 
Study 
equation) 
≥4000 g 1.77) kidney disease, 
HTN control 
19 Salmi A, 
et al. 
(2008) 
45
 
Austra
lia 
Case-
control 
study 
56
7 
60.3±15; 
both sex 
Cases were 
patient 
attended the 
Nephrology 
department. 
Controls were 
sex and 
closely 
matched age 
participated in 
AusDiab 
study; 
[case:3270±6
20; 
control:3460±
590] 
CKD stages 
2-5: eGFR 
60-90 
mL/min/1.7
3 m
2
 with 
proteinuria 
hematuria 
or 
eGFR<60 
mL/min/1.7
3 m
2
 
(MDRD 
Study 
equation), 
or on 
dialysis 
therapy 
LBW significantly more 
prevalent in patients 
with CKD compared 
with age- & sex-
matched controls 
BW <2,500 
g (v 2,500-
3,999 g) 
3.60 (1.70, 
7.60) 
Age, sex, diabetes, 
hypertension, 
glomerulonephritis, 
and reno-vascular 
disease 
20 Hannaw
i S, et al. 
(2012) 
46
 
Austra
lia 
Cohort 
study 
10
17 
29-30  As like as 
Salmi A, et al. 
(2008) 
eGFR 
(mL/min/1.
73 m
2
) 
Birth weight was 
strongly associated with 
eGFR 
 3.17 (2.00, 
4.35)* 
 
21 Vikse 
BE, et 
al. 
Norwa
y 
Retrospe
ctive 
cohort 
2.2 
mil
lio
Age 
ESRD 
onset 
Record 
linkage study 
of all 
ESRD LBW & BW for 
gestational age 
significantly associated 
BW <2,500 
g (v 2,500-
4,499 g) 
2.00 (1.4, 
2.8) 
Sex, birth year, 
birth order, 
congenital 
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(2008) 
47
 study n 21.2±8.9; 
both sex 
Norwegian 
children born 
1967-2004 
with risk of ESRD HBW 
≥4000 g 
3.2 (0.75, 
13.4) 
malformation, 
multiple delivery, 
maternal factors 
(age, marital status, 
preeclampsia) 
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Table 1: Summary tables of studies measure estimated Chronic Renal Disease and use effect size as Odds ratio/Beta-coefficient (continuation) 
 
 
 Study 
name 
Place Study 
design  
N Age 
(year; 
mean±SD
) and sex 
Patient’s 
character 
Biomarker Findings  Exposure 
(reference) 
OR/β 
(95% CI) 
Adjusted/Potentia
l predictors 
2
2 
Harrison 
SL, et al. 
(2013) 
48
 
United 
Kingdo
m 
Cohort 
study 
33
5 
63-64; 
both sex  
Cohort of the 
Newcastle 
Thousand 
Families 
study 
eGFR 
(mL/min/1.
73 m
2
) 
BW was significantly 
positively associated 
with eGFR. 
 
3.85 (0.48, 
7.23)* 
Sex, smoking and 
BMI  
2
3 
Oster RT, 
et al. 
(2013) 
49
 
Canada Cohort 
study 
14
39 
32.1±17.2 
(5-90); 
both sex 
Canadian 
aboriginal  
Dipstick-
positive 
proteinuria 
and/or 
ACR>2.74 
in females 
or >1.94 in 
males  
LBW was significantly 
associated with 
proteinuria 
LBW≤2500 
g  (v ≥2,500 
g) 
2.36 (1.24, 
4.49) 
Age and sex 
  
HBW was not 
associated with 
proteinuria 
HBW≥4000 
g 
0.56 (0.23, 
1.38) 
2
4 
Silverwo
od RJ, et 
United 
Kingdo
Cohort 
study 
21
98 
62-64 
Singleton 
children born 
C 
(eGFRcys) 
LBW was significantly 
associated with renal 
 2.24 (0.80, 
3.69)* 
Age, sex, self-
reported diabetes 
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al. (2013) 
50
 
m in 1 week in 
March 1946 
in England, 
Scotland, and 
Wales 
LogACR disease 0.010 (-
0.065, 
0.085)* 
and  midlife SBP 
trajectory,  
treatment of DM 
and HTN at 60–64, 
SBP at 60–64; 
overweight at 36 
years 
2
5 
Bakker 
H, et al. 
(2014) 
51
 
Netherl
ands  
Cohort 
study  
64
82 
6; both 
sex 
Generation R 
study 
eGFR Higher gestational age-
adjusted birth weight 
was associated with 
higher eGFR 
 0.78 (0.16, 
1.39)* 
Gestational age 
2
6 
Berglund 
D, et al. 
(2014) 
52
 
United 
States  
Cohort 
study 
21
6 
52.2± 9.6; 
both sex  
Living donor 
nephrectomie
s  
GFR using 
the plasma 
clearance of 
non-
radioactive 
iohexol<60 
mL/min/1.7
3 m
2
 
BW was not associated 
with GFR 
LBW<2500 
g 
 
0.70 (0.28, 
1.74)  
Age, sex, BMI, 
time from 
donation,  SBP, 
DBP 
2
7 
Hoy WE, 
et al. 
(2014) 
53
 
Australi
a 
Retrospe
ctive 
Cohort 
study  
65
5 
15-39 
(26.2) 
Remote 
aboriginal 
people  
LogACR 
BW was associated log 
transformed ACR 
 
-0.71 (-
1.21, -
0.18)*  
Age, BMI at 
follow-up, a 
previous post 
streptococcal 
glomerulo-nephritis 
2 Hsu CW, 
et al. 
United Case-
control 
22
02
<1-35; Cases were 
individuals 
Diagnosed 
by ICD-9 
LBW significantly LBW<2500 
g (v ≥2,500 
2.88 (2.28, Maternal DM, 
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8 (2014) 
54
 States  study   6 both sex with renal 
dysplasia/ 
aplasia and 
obstructive 
uropathy. 
Control had 
no  history of 
CKD in 
matched by 
year of birth 
to cases in a 
10:1 ratio 
codes [renal 
dysplasia/ 
aplasia 
753.0/753.1
5) and 
obstructive 
uropathy 
(599.6/753.
2)] 
 
increased risk of CKD g) 3.63)  BMI, and smoking  
HBW was not 
associated with  risk of 
CKD 
HBW≥4000 
g 
0.97 (0.79, 
1.21) 
Maternal BMI and 
smoking 
 
Note: *effect size in beta coefficient otherwise odds ratio; ACR: albumin creatinine ratio; AER: albumin extrication rate; BMI: body mass index; 
BW: Birth weight; CKD: chronic renal disease; DM: diabetes mellitus; ELBW: extreme low birth weight; HBW: High birth weight; GFR: 
Glomerular filtration rate; eGRF: estimated GFR; LBW: low birth weight; IGT: impaired glucose tolerance test; IDDM: insulin dependent 
diabetes mellitus; MDRD: modified diet for renal disease;  NIDDM: non-insulin dependent diabetes mellitus; SGA: Small for gestation; SPB: 
systolic blood pressure; DBP: diastolic blood pressure.  
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Table 2: Summary tables of studies measure mean difference of different biomarker for assessment of renal function  
 
  Study 
name 
Place Study 
design  
Age 
(year; 
mean
±SD) 
and 
sex) 
Patient’s 
character 
Biomarke
r 
Findings  Adjusted/P
otential 
predictors 
LBW Control 
N BW GFR N BW GFR 
1 
Vanpée 
M, et al. 
(1992) 
55
 
Sweden 
Cross-
section
al study 
8 
18 months post-
conceptual age 
infants  
GFR 
#Renal function 
markedly reduced 
during the neonatal 
period in very low 
birth weight infants  
 2
2 
VLB
W 
(GA 
28.2±
1.5 
weeks
) 
103±
12 
25  107±1
0 
2 Hoy 
WE, et 
al. 
(1999) 
29
#  
Australi
a 
Cohort 
study 
20-38 
Adults aged 
over 20 years 
and above   
ACR 
(Urine) 
LBE contributes to 
renal disease 
compared to higher 
birth weight 
Unadjusted 1
1
1 
2220±
270 
3.1±5
.64 
20
6 
2960±
330 
2.2±4.
03 
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3 
McAllist
er AS, et 
al. 
(1999) 
56
 
Ireland 
Cohort 
study 
- Healthy 
Caucasian 
volunteers, half 
low BW, half 
normal BW, all 
full term 
ACR 
No significant 
differences in mean 
serum creatinine, 
ACR. or AER 
between subjects 
with BW  2.500 v 
3,000-4,000 g 
 1
2 
28.0±
0.21 
0.6±0
.58 
12 27.9±
0.29 
0.44±
0.24 
4 
Bo S, et 
al. 
(2000) 
57
 
Italy 
Cohort 
study 
33.7±
7.5 
Twins without a 
familial history 
of diabetes and 
hypertension 
ACR 
(Urine) 
No significant 
correlation between 
BW & AER 
 3
6 
2440±
610 
3.19±
3.69 
36 2719±
0.06 
2.84±
2.59 
5 
Kistner 
A, et al. 
(2000) 
58
 
Sweden 
Case-
control 
study  
26±1.
9 
Women selected 
from hospital 
records & birth 
register, 15 
preterm, 18 full-
term SGA (BW  
2,600 g), 17 
full-term 
appropriate BW 
GFR 
No significant 
differences in GFR 
between preterm 
and full term with 
appropriate BW 
individuals 
Unadjusted 1
5 
1293±
283 
103±
11 
17 3720±
313 
107±1
4 
6 Vasarhel
yi B, et 
al. 
(2000) 
32
# 
Hungar
y 
Cohort 
study 
20-22 Healthy 
adolescents 
GFR No association 
between LBW and 
kidney function 
observed  
Sex 4
9 
 127±
22 
16  125±1
7 
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7 
Gielen 
M, et al. 
(2005) 
59
 
The 
Netherl
ands  
Cohort 
study 
25.6±
4.7 
Monozygotic 
and dizygotic 
twins 
GFR (24-h 
CC) 
No significant 
difference in 
creatinine 
clearance between 
twins who both had 
LBW as compared 
with twins who 
both had a HBW 
Unadjusted 3
0
4 
2131±
270 
93±3
4 
34
9 
2878±
314 
94±22 
8 
Keijzer-
Veen 
MG, et 
al. 
(2005) 
36
# 
The 
Netherl
ands  
Cohort 
study 
19.3±
0.2 
 
GFR 
GFR was 
significantly lower 
among SGA  
compared to AGA 
Sex  2
1
5 
1144±
259 
105.1
±16 
20
7 
1496±
317 
108.9
±15.4 
9 
Rodrigu
ez-
Soriano 
J, et al. 
(2005) 
60
 
Spain  
Case-
control 
study  
6.1-
12.4 
(8.6) 
School-age 
children. Case 
were born with 
BW<1000g; 
controls were 
health children 
of same age 
GFR GFR is 
significantly 
diminished in 
school-age children 
born with extreme 
prematurity 
Unadjusted 4
0 
540-
100 
117±
17 
43 --- 131±1
7 
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1
0 
Fagerud
d J, et al. 
(2006) 
39
# 
 
Finland 
 
 
Cohort 
study 
33±9 Percipients with 
a diagnosis of 
type 1 diabetes 
(E10 in ICD-10) 
attending the 
diabetic and 
renal out patient 
clinics and 
dialysis units 
GFR (CC) 
 
 
End-stage renal 
disease were 
equally prevalent in  
the various birth 
weight groups 
         --- 1
5
4 
2510±
210
†
 
90±2
6 
62
2 
2810±
190
†
 
69±29 
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Table 2: Summary tables of studies measure mean difference of different biomarker for assessment of renal function (continuation) 
 
  Study 
name 
Place Study 
design  
Age 
(year; 
mean
±SD) 
and 
sex) 
Patient’s 
character 
Biomarke
r 
Findings  Adjusted/P
otential 
predictors 
LBW Control 
N BW GFR N BW GFR 
1
1 Lopez-
Bermejo 
A, et al. 
(2008) 
61
 
Spain 
 
Cross-
section
al study 
9.5 ± 
0.4; 
both 
sex 
Healthy school-
age children 
GFR 
Significant 
decrease in the 
eGFR was evident 
between lower and 
upper tertail of 
BW-SD score 
Age, sex, 
GA, BMI 
 -2.0 to 
-0.7 
101±
7.49  
 -0.1 to 
1.6 
121±1
4.99 
1
2 
Bacchett
a J, et al. 
(2009) 
62
 
France  
Cohort 
study  
5.8-
10.3 
(7.6±1
.3) 
IUGR 
(BW<1000g 
and/or <32 wk 
GA); 
normotrophic 
(premature 
children with a 
BW above -2 
SD and birth, 
and  height at 
discharge above 
-2 SD for 
corresponding 
ACR 
Inborn with  IUGR 
were at risk of 
decrease ACR 
during childhood 
Unadjusted 2
3 
IUGR  1.5±1
.2 
11 Norm
otrop-
hic 
1.9±1.
6 
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GA  
1
3 
Berglun
d D, et 
al. 
(2014) 
52
# 
United 
States  
Cohort 
study 
 41±10
.3 
Nephrectomies 
living donor 
free from 
diabetes, 
hypertension 
and have a GFR 
> 80 mL/min 
GFR Birth weight was 
not associated with 
GFR <60 
ml/min/1.73m2, 
but was associated 
with albuminuria 
 1
5 
--- 69.6±
11.9 
20
1 
---- 72.3±
11.6 
ACR 
(Blood) 
4.0±2
6.7 
20±10 
 
Note: ACR: albumin creatinine ratio; AGA: Appropriate for gestational age; BMI: body mass index; BW: Birth weight; CC:Creatinine clearance 
GA: Gestational age; GFR: Glomerular filtration rate; LBW: low birth weight; SGA: Small for gestation; SPB: systolic blood pressure; DBP: 
diastolic blood pressure; VLBW: very low birth weight; †ponderal index (kg/m3); #detail describe in Table 1;  
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Table 3: Summary of the studies not included in the meta-analysis 
 
 
Study 
name 
Place 
Study 
design  
N 
Age 
(avg.) 
Patient 
character 
Method/Bio
markers 
used  
Findings  
1 
Sandema
n DD et 
al. 
(1992) 
63
 
United   
Kingdo
m 
Cohort 
study 
45 
<40; 
both sex 
Patient of 
T1DM 
Microalbumi
nuria or 
proteinuria 
Individuals with 
albuminuria/ 
proteinuria had 
significantly  lower 
BW than those 
without nephropathy 
2 
Rossing 
P, et al. 
(1995) 
64
 
Denmar
k 
Case-
control  
36
6 
Cases, 
41.0±9.3
; 
controls, 
42.1±9.8
; both 
sex 
Patients with 
IDDM with or 
without 
diabetic 
nephropathy 
Diabetic 
nephropathy 
(persistent 
AER ≥300 
mg/24 h) 
Prevalence of 
diabetic nephropathy 
significantly higher 
in LBW women 
compared with high 
BW; no significant 
difference in men 
3 
Vestbo 
E, et al. 
(1996) 
65
 
Denmar
k 
Cross-
section
al study  
62
0 
48 
(median) 
Offspring of 
participants 
excluding 
subjects with 
DM or overt 
nephropathy 
AER 
No significant 
relationship between 
BW & AER 
4 
Yudkin 
JS, et al. 
(1997) 
66
 
United   
Kingdo
m 
Cohort 
study 
23
6 
 46-54; 
both sex 
Study of 
participants 
born in & 
around 
Leningrad 
from January 
1941-July 
1942 before & 
during siege of 
Leningrad 
AER 
Consistent 
relationships of short 
stature with 
microalbuminuria 
and nephropathy in 
diabetic and non-
diabetic individuals.  
5 
Erbey J, 
et al. 
(1997) 
67
 
United 
States  
Cohort 
study 
67 
26.8; 
both sex 
Patients with 
IDDM; mean 
duration of 
IDDM 18.1 
years  
Early onset 
albuminuria 
(AER ≥200  
micg/min, 
onset at  21.8 
y IDDM 
duration) 
No association 
between LBW and 
shorter duration of 
IDDM at first 
presentation of 
albuminuria 
6 Johnsen 
SP, et al. 
Denmar
k 
Nested 
study 
54
5 
40.7±5.6 
 
Participants 
available birth 
ACR No significant 
associations between 
  
This article is protected by copyright. All rights reserved. 
(2001) 
68
 
 
 
 
 
 
(popula
tion-
based 
RCT)  
 
 
records 
 
 
BW, birth length, or 
ponderal index and 
ACR adjusted for 
age, BMI, smoking, 
alcohol consumption 
7 
Eshoj O, 
et al. 
(2002) 
69
 
Denmar
k 
Case-
control 
study 
10
2 
38 
(median)
; both 
sex 
Patient of 
T1DM 
Diabetic 
nephropathy 
(AER   ≥200 
micg/min 
and/or 
ESRD) 
No significant 
correlation between 
BW and AER or 
difference in 
prevalence of LBW 
between cases and 
controls 
8 
Iotova et 
al. 
(2002) 
70
 
Bulgari
a 
Case-
control 
study 
90 
With 
MA, 
20.9±2.6
; no MA, 
19.4±3.4 
Adolescents 
with T1DM 
Microalbumi
nuria 
Subjects with 
microalbuminuria 
had significantly 
lower BW than 
controls 
9 
Laganovi
c et al. 
(2002) 
71
 
Croatia 
Cohort 
study 
72 38 
Patients with 
mild form of 
essential 
hypertension 
Microalbumi
nuria 
No difference in 
albumin excretion 
between subjects 
with BW 3,250 g 
and others 
1
0 Huxley 
RR, et al. 
(2004) 
72
 
 
 
 
United 
Kingdo
m  
 
 
 
Cohort 
study  
 
13
7 
 
both sex Offspring of 
pregnant 
mothers who 
participated 
in a wartime 
dietary survey 
ACR No significant 
relationship between 
BW and ACR 
adjusted for age, 
gender, BMI, 
parental social class 
and current social 
class  
1
1 
Iacobelli 
S, et al. 
(2007) 
73
 
France  
Cohort 
study 
96  7.2±0.6   
Urine 
microlabumi
n  
VLBW infants is not 
correlated with urine 
microlabumin  
1
2 
Kwinta 
P, et al. 
(2011) 
74
 
 
 
 
Poland 
 
 
 
 
Cohort 
study 
 
 
 
 
11
6 
6.7; both 
sex 
Case children 
born as ELBW 
infants; control 
born full-term 
AER 
 
 
 
 
No significant 
difference in AER 
between inborn with  
ELBW and full-term 
 
 
1
3 
Cassidy-
Bushrow 
AE, et al. 
United 
States 
Cohort 
study 
15
2 
25±35 
(30) 
African and 
non-African 
American 
LogGFR 
BW is associated 
with renal function 
in African American 
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(2012) 
75
 children 
1
4 
 
Ichikawa 
T, et al. 
(2012) 
76
 
 
Japan 
Cohort 
study 
-- --- 
The numbers 
of LBW 
(<2,500 g) 
babies and  
ESRD need 
dialysis in 11 
prefectures of 
Japan was 
included.   
ESRD 
The annual 
incidence of LBW 
was positively 
correlated with 
annual incidence of 
ESRD  
1
5 
Flynn 
JT, et al. 
(2014) 
77
 
United 
States 
Cohort 
study 
33
2 
1-16 (12) 
Children born 
with normal 
and abnormal 
weight [LBW 
(<2500 g), 
premature 
birth (<36 
wk.), SGA 
(BW <10
th
 
percentile of 
GA)] 
GFR  
Abnormal birth 
history did  not 
significant  GFR in 
this cohort of 
children with CKD 
adjusted for age, sex 
and height 
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Table 4: Sensitivity analysis 
 
Characters  
Biomarker  
Blood Urine 
LBW and CKD 
Geography 
  
    USA and Canada 
1.59 (1.15, 
2.20) 
1.64 (1.06, 
2.55) 
    Europe 
1.85 (1.36, 
2.53) 
1.56 (0.95, 
2.55) 
    Asia and Australia 
2.68 (1.73, 
4.15) 
2.28 (1.17, 
4.43) 
Age*  
  
     ≤30 years 
2.30 (1.76, 
3.00) 
1.26 (0.79, 
1.99) 
    31-50 years 
1.57 (1.54, 
4.18) 
1.90 (1.28, 
2.84) 
    ≥51 years 
3.66 (1.8, 
7.42) 
3.10 (0.90, 
11.3) 
Individual with Diabetic  
  
    Diabetic 
2.51 (1.99, 
3.17) 
1.38 (0.96, 
1.99) 
    Non-diabetic 
1.85 (1.41, 
2.420 
2.18 (1.46, 
3.27) 
Ethnic origin  
  
    Aborigine  - 
2.32 (1.43, 
3.75) 
    Non-aborigine - 
1.50 (1.08, 
2.09) 
HBW and CKD (overall) 
Geography 
 
    USA and Canada 1.10 (0.91, 1.32) 
    Europe 1.12 (0.61, 2.06 
*Total 20 studies included in the analysis 
#Only limited to studies used urine sue to none of the studies 
among aboriginal population used blood specimen 
 
 
 
 
 
